Results 21 to 30 of about 317,910 (262)

Targeted therapy in age-related macular degeneration (AMD)

open access: yesJournal of Education, Health and Sport, 2020
Introduction and purpose: Age-related macular degeneration (AMD) is a major cause of blindness in highly developed countries, with blindness frequency of 8.7%.
Klaudia Daria Szumna   +4 more
doaj   +1 more source

DNA Vaccine Construct Formation using Mycobacterium-Specific Gene Inh-A

open access: yesJournal of Preventive, Diagnostic and Treatment Strategies in Medicine, 2022
BACKGROUND: Tuberculosis (TB) remains a highly contagious disease and a leading cause of death worldwide. It is caused by Mycobacterium tuberculosis and Mycobacterium bovis. TB infection is still uncontrolled because of the unavailability of an effective
Summayya Anwar   +4 more
doaj   +1 more source

Genetic and Chemical Capsid Modifications of Adenovirus Vectors to Modulate Vector–Host Interactions

open access: yesViruses, 2021
Adenovirus-based vectors are playing an important role as efficacious genetic vaccines to fight the current COVID-19 pandemic. Furthermore, they have an enormous potential as oncolytic vectors for virotherapy and as vectors for classic gene therapy ...
Denice Weklak   +5 more
doaj   +1 more source

An optimized retroviral toolbox for overexpression and genetic perturbation of primary lymphocytes

open access: yesBiology Open, 2022
Genetic manipulation of primary lymphocytes is crucial for both clinical purposes and fundamental research. Despite their broad use, we encountered a paucity of data on systematic comparison and optimization of retroviral vectors, the workhorses of ...
Lieve E. H. van der Donk   +7 more
doaj   +1 more source

Molecular Genetic Manipulation of Vector Mosquitoes [PDF]

open access: yesCell Host & Microbe, 2008
Genetic strategies for reducing populations of vector mosquitoes or replacing them with those that are not able to transmit pathogens benefit greatly from molecular tools that allow gene manipulation and transgenesis. Mosquito genome sequences and associated EST (expressed sequence tags) databases enable large-scale investigations to provide new ...
Terenius, Olle   +3 more
openaire   +2 more sources

A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA

open access: yesPharmaceutics, 2022
Cancer is the leading cause of death worldwide. Tumors consist of heterogeneous cell populations that have different biological properties. While conventional cancer therapy such as chemotherapy, radiotherapy, and surgery does not target cancer cells ...
Ioana Toma   +4 more
doaj   +1 more source

Genetic elimination of dengue vector mosquitoes [PDF]

open access: yesProceedings of the National Academy of Sciences, 2011
An approach based on mosquitoes carrying a conditional dominant lethal gene (release of insects carrying a dominant lethal, RIDL) is being developed to control the transmission of dengue viruses by vector population suppression. A transgenic strain, designated OX3604C, of the major dengue vector, Aedes aegypti , was
Megan R, Wise de Valdez   +6 more
openaire   +2 more sources

Leaning Into the Bite: The piRNA Pathway as an Exemplar for the Genetic Engineering Need in Mosquitoes

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
The piRNA pathway is a specialized small RNA interference that in mosquitoes is mechanistically distant from analogous biology in the Drosophila model.
Vanessa M. Macias   +5 more
doaj   +1 more source

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Background: Genetic immunization is expected to induce the expression of antigens in a native form. The encoded peptide epitopes are presented on endogenous MHC molecules, mimicking antigen presentation during a viral infection.
S. Stenler   +12 more
doaj   +1 more source

Expression, Purification and Characterization of Ricin vectors used for exogenous antigen delivery into the MHC Class I presentation pathway

open access: yesBiological Procedures Online, 2003
Disarmed versions of the cytotoxin ricin can deliver fused peptides into target cells leading to MHC class I-restricted antigen presentation [Smith et al. J Immunol 2002; 169:99-107].
Smith Daniel C.   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy